Company Name | Pfizer, Inc. |
---|---|
Website | https://www.pfizer.com |
Snippet | First subjects vaccinated in study of Pfizer’s RSV bivalent prefusion F subunit investigational vaccine candidate in adults ages 60 or older RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR ( R SV vaccine E fficacy study i N O lder adults I mmunized ... |
Type | Public |
Founded | 1849 |
Revenue | $41.908 billion (2020) |
Website | www.pfizer.com |
Founders | Charles Pfizer, Charles F. Erhart |
Industry | Pharmaceutical, Biotechnology |
Products | Pharmaceuticals, vaccines |
Traded as | NYSE: PFE, S&P 100 component, S&P 500 component, Russell 1000 Index component |
Key people | Albert Bourla, Chairman & CEOFrank A. D’Amelio, CFOMikael Dolsten, CSOLidia Fonseca, CTOScott Gottlieb, DirectorHelen Hobbs, DirectorSusan Hockfield, DirectorDan Littman, DirectorShantanu Narayen, DirectorSuzanne Nora Johnson, DirectorJames Quincey, DirectorJim Smith, Director |
Net income | $9.615 billion (2020) |
Area served | Worldwide |
Headquarters | 235 East 42nd Street, New York City, U.S. |
Total assets | $178.983 billion (2020) |
Total equity | $65.495 billion (2020) |
Operating income | $8.16 billion (2020) |
Number of employees | 78,500, of whom 29,400 are in the United States (2020) |
Pfizer, Inc. is part of the United States company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us